List your tool

Head to head · 2026

AISAP vs Proscia

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

AISAP

An FDA-cleared AI platform that reads cardiac ultrasound images at the bedside in real time

4.1Not listed

Visit AISAP (opens AISAP in a new tab)

Proscia

FDA-cleared digital pathology platform for primary diagnosis and biomarker research

4.3Not listed

Visit Proscia (opens Proscia in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: AISAP does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Proscia

    4.1 against 4.3

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onAISAPProscia
Our rating4.14.3Better
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Real-time AI interpretation of cardiac ultrasound images at the bedside
  • FDA clearance in the CADx pathway for structural heart disease diagnosis via POCUS
  • Structured, auto-generated reporting that cuts documentation time
  • Works with existing ultrasound hardware rather than a proprietary probe
  • Integrates with PACS and EMR systems already in place
  • FDA-cleared for primary clinical diagnosis in AP-Dx
  • Concentriq AP, AP-Dx and LS configurations
  • Biomarker research and clinical trial workflows
  • Cloud deployment
  • Predetermined Change Control Plan for regulatory compliance
Pros
  • FDA clearance gives it regulatory standing competitors without clearance lack
  • Hardware-agnostic approach avoids locking hospitals into new ultrasound equipment
  • Backed by practicing cardiologists as co-founders, not only engineers
  • FDA clearance for primary diagnosis, not just research viewing
  • Deployed across 4,000 hospitals and 16 of the top 20 pharma companies
  • Rated highest in KLAS 2026 in both the US and Europe
Cons
  • Pricing is entirely custom and undisclosed, making budget comparison hard upfront
  • Aimed at institutions rather than individual clinicians shopping for a personal tool
  • Regulatory clearance is specific to cardiac and structural heart disease, not general ultrasound reading
  • No published pricing
  • Requires compatible scanning hardware
  • Adoption is a laboratory-wide programme, not a purchase
CompanyAISAP, founded 2021Proscia Inc.

Prices come from each vendor's pricing page, last checked 20260814. Check the vendor before you buy.

FAQ

Questions people ask

Is AISAP better than Proscia?

In our reviews AISAP scores 4.1 and Proscia scores 4.3. The better pick depends on the job. AISAP: An FDA-cleared AI platform that reads cardiac ultrasound images at the bedside in real time. Proscia: FDA-cleared digital pathology platform for primary diagnosis and biomarker research.

Which is cheaper, AISAP or Proscia?

AISAP: see pricing. Proscia: see pricing.

Do AISAP and Proscia have free plans?

Neither lists a free plan.

More comparisons

AISAP compared with

All AISAP alternatives

Proscia compared with

All Proscia alternatives